SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001694187-19-000052
Filing Date
2019-06-27
Accepted
2019-06-27 08:27:35
Documents
2
Period of Report
2019-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_156163844021811.html 4  
1 FORM 4 wf-form4_156163844021811.xml 4 4001
2 EXHIBIT 24.1 - POWER OF ATTORNEY (SHERWIN) ex-24.htm EX-24 4026
  Complete submission text file 0001694187-19-000052.txt   9470
Mailing Address C/O CELL GENESYS, INC. 500 FORBES BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address
SHERWIN STEPHEN A (Reporting) CIK: 0001079462 (see all company filings)

State of Incorp.: DE
Type: 4 | Act: 34 | File No.: 001-38551 | Film No.: 19923007

Mailing Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 110 CAMBRIDGE MA 02139 617-337-4701
Neon Therapeutics, Inc. (Issuer) CIK: 0001694187 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences